Telesis Bio (TBIO) Competitors $0.55 +0.09 (+19.15%) As of 04/29/2025 03:24 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainSEC FilingsTrendsBuy This Stock TBIO vs. TLIS, SMIT, SPEC, THMO, HTGMQ, OLITW, PRENW, QSIAW, SMAPW, and TTShould you be buying Telesis Bio stock or one of its competitors? The main competitors of Telesis Bio include Talis Biomedical (TLIS), Schmitt Industries (SMIT), Spectaire (SPEC), ThermoGenesis (THMO), HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), and Trane Technologies (TT). These companies are all part of the "measuring and control equipment" industry. Telesis Bio vs. Talis Biomedical Schmitt Industries Spectaire ThermoGenesis HTG Molecular Diagnostics OmniLit Acquisition Prenetics Global Quantum-Si SportsMap Tech Acquisition Trane Technologies Talis Biomedical (NASDAQ:TLIS) and Telesis Bio (NASDAQ:TBIO) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, community ranking, media sentiment, analyst recommendations and institutional ownership. Does the MarketBeat Community favor TLIS or TBIO? Talis Biomedical and Telesis Bio both received 9 outperform votes by MarketBeat users. However, 52.94% of users gave Telesis Bio an outperform vote while only 37.50% of users gave Talis Biomedical an outperform vote. CompanyUnderperformOutperformTalis BiomedicalOutperform Votes937.50% Underperform Votes1562.50% Telesis BioOutperform Votes952.94% Underperform Votes847.06% Which has better valuation and earnings, TLIS or TBIO? Telesis Bio has higher revenue and earnings than Talis Biomedical. Talis Biomedical is trading at a lower price-to-earnings ratio than Telesis Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTalis Biomedical$300K9.72-$62.01M-$28.02-0.06Telesis Bio$225.09M0.00-$47.72M-$28.20-0.02 Is TLIS or TBIO more profitable? Talis Biomedical has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%. Telesis Bio's return on equity of 0.00% beat Talis Biomedical's return on equity.Company Net Margins Return on Equity Return on Assets Talis BiomedicalN/A -79.74% -57.16% Telesis Bio -336.59%N/A -61.89% Do institutionals & insiders hold more shares of TLIS or TBIO? 43.8% of Talis Biomedical shares are owned by institutional investors. Comparatively, 37.6% of Telesis Bio shares are owned by institutional investors. 46.0% of Talis Biomedical shares are owned by company insiders. Comparatively, 24.5% of Telesis Bio shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the media refer more to TLIS or TBIO? In the previous week, Talis Biomedical's average media sentiment score of 0.00 equaled Telesis Bio'saverage media sentiment score. Company Overall Sentiment Talis Biomedical Neutral Telesis Bio Neutral Which has more volatility and risk, TLIS or TBIO? Talis Biomedical has a beta of 1.33, meaning that its share price is 33% more volatile than the S&P 500. Comparatively, Telesis Bio has a beta of 1.57, meaning that its share price is 57% more volatile than the S&P 500. SummaryTalis Biomedical and Telesis Bio tied by winning 6 of the 12 factors compared between the two stocks. Get Telesis Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TBIO vs. The Competition Export to ExcelMetricTelesis BioAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$991,000.00$4.16B$5.57B$7.83BDividend YieldN/A0.58%5.11%4.21%P/E Ratio-0.0227.2922.4418.48Price / Sales0.004.24394.10103.59Price / CashN/A36.1438.1834.62Price / Book3.931.686.774.25Net Income-$47.72M-$83.57M$3.22B$248.23M7 Day Performance-38.90%-3.02%3.25%3.29%1 Month Performance89.62%-1.80%0.01%2.42%1 Year Performance-91.54%-32.84%18.00%5.54% Telesis Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TBIOTelesis BioN/A$0.55+19.2%N/A-91.5%$991,000.00$225.09M-0.02200Gap DownTLISTalis BiomedicalN/A$1.60-5.9%N/A-81.4%$2.92M$300,000.00-0.06260Upcoming EarningsGap DownSMITSchmitt IndustriesN/A$0.02flatN/A-30.0%$72,000.00$9.89M0.00160Gap UpSPECSpectaireN/A$0.00flatN/A-99.8%$20,000.00N/A0.008THMOThermoGenesisN/A$0.00-85.7%N/AN/A$1,000.00$9.61M0.0040Gap DownHTGMQHTG Molecular DiagnosticsN/AN/AN/AN/A$0.00$6.37M0.0090OLITWOmniLit AcquisitionN/A$0.04-13.9%N/A-71.8%$0.00N/A0.003High Trading VolumePRENWPrenetics GlobalN/A$0.01+2.0%N/A+24.0%$0.00$25.56M0.001Short Interest ↓Negative NewsGap DownQSIAWQuantum-SiN/A$0.35+4.5%N/A+52.2%$0.00$3.06M0.00150SMAPWSportsMap Tech AcquisitionN/A$0.06-8.0%N/AN/A$0.00N/A0.00N/ATTTrane Technologies3.9378 of 5 stars$322.29-3.3%$405.31+25.8%+20.8%$72.29B$19.84B28.6539,000Earnings ReportAnalyst UpgradeNews CoveragePositive NewsGap Up Related Companies and Tools Related Companies Talis Biomedical Competitors Schmitt Industries Competitors Spectaire Competitors ThermoGenesis Competitors HTG Molecular Diagnostics Competitors OmniLit Acquisition Competitors Prenetics Global Competitors Quantum-Si Competitors SportsMap Tech Acquisition Competitors Trane Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TBIO) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telesis Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Telesis Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TBIO Stock Free TBIO Stock Alerts